The causes of tendinopathy are complex and not fully understood but the results – ranging from mild pain and swelling to complete loss of function – and the frustratingly slow recovery can be devastating, particularly for an athlete. The current consensus is that the best treatment is a careful programme of strengthening and load management. This article clearly describes how to tailor a rehab programme to your patient’s precise needs, and, importantly, what not to do.
This article offers a ‘how to’ guide for diagnosing Achilles tendinopathy. We describe the differential diagnoses and look carefully at the history taking, examination methods and imaging techniques that are useful in diagnosing Achilles tendinopathy.... Read More
This article is an overview of a review by Malliaras et al. (1) looking at Achilles and patellar tendinopathy rehabilitation. There has been much research into the pathophysiology of tendinopathy and management of the condition... Read More
In the October 2012 issue of sportEX medicine I reviewed the current evidence and theories relating to Achilles tendinopathy. While many theories are still in situ the one that appears to have gained the most... Read More
Thank you. Your account has been created and you have now been logged in. We will send you an email so that you can set your password for future use.
Unfortunately your current subscription does not include access to the new Co-Kinetic Business Growth and Marketing section. This is either because you have an old legacy Full Site subscription which requires an upgrade or you have another subscription which doesn't include access to the Business Growth element of the site.
This new part of the Co-Kinetic platform is designed to:
To access this new section, we need you to upgrade to add the Business Growth subscription to your account. (more details here).
Don't worry, it's RISK FREE. If you don't wish your subscription to continue after this time, simply cancel your Business Growth subscription before the trial expires and your original content subscription will continue as before.
